Different mechanisms of inflammation induced in virus and autoimmune-mediated models of multiple sclerosis in C57BL6 mice

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Kishore, Abhinoy ^a   Kanaujia, Anurag ^b   Nag, Soma ^a   Rostami, A M ^c   Kenyon, Lawrence C ^c   Shindler, Kenneth S ^d   Das Sarma, Jayasri ^a,c  

^a INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH KOLKATA   (India)

^b INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH MOHALI   (India)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AXONAL INJURY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DEMYELINATING DISEASE; HISTOPATHOLOGY; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; REMISSION; TOXICITY; VIRUS INFECTION; VIRUS REPLICATION; WHITE MATTER; ANIMAL; BRAIN; C57BL MOUSE; DISEASE MODEL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; HUMAN; IMMUNOLOGY; MURINE HEPATITIS CORONAVIRUS; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; SPINAL CORD; VIROLOGY; VIRULENCE; COMPLICATION; MURINE HEPATITIS VIRUS;

ANIMALS; BRAIN; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; INFLAMMATION; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; MURINE HEPATITIS VIRUS; SPINAL CORD; VIRULENCE; VIRUS REPLICATION;

EID: 84884275608     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/589048     Document Type: Article

References (41)

1. Noseworthy J. H., Lucchinetti C., Rodriguez M., Weinshenker B. G., Multiple sclerosis. The New England Journal of Medicine 2000 343 13 938 952 2-s2.0-0034727066 10.1056/NEJM200009283431307
2. Martin R., McFarland H. F., McFarlin D. E., Immunological aspects of demyelinating diseases. Annual Review of Immunology 1992 10 153 187 2-s2.0-0026645658
3. Sospedra M., Martin R., Immunology of multiple sclerosis. Annual Review of Immunology 2005 23 683 747 2-s2.0-17644396349 10.1146/annurev.immunol.23. 021704.115707
4. Sawcer S., Jones H. B., Feakes R., Gray J., Smaldon N., Chataway J., Robertson N., Clayton D., Goodfellow P. N., Compston A., A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nature Genetics 1996 13 4 464 468 2-s2.0-15844368830 10.1038/ng0896-464
5. Ebers G. C., Genetic epidemiology of multiple sclerosis. Current Opinion in Neurology 1996 9 3 155 158 2-s2.0-0029901821
6. Ebers G. C., Kukay K., Bulman D. E., Sadovnick A. D., Rice G., Anderson C., Armstrong H., Cousin K., Bell R. B., Hader W., Paty D. W., Hashimoto S., Oger J., Duquette P., Warren S., Gray T., O'Connor P., Nath A., Auty A., et A., A full genome search in multiple sclerosis. Nature Genetics 1996 13 4 472 476 2-s2.0-15844366743 10.1038/ng0896-472
7. Haines J. L., Ter-Minassian M., Bazyk A., Gusella J. F., Kim D. J., Terwedow H., Pericak-Vance M. A., Rimmler J. B., Haynes C. S., Roses A. D., Lee A., Shaner B., Menold M., Seboun E., Fitoussi R.-P., Gartioux C., Reyes C., Ribierre F., Gyapay G., et A., A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nature Genetics 1996 13 4 469 471 2-s2.0-0009573338 10.1038/ng0896-469
8. + T cells expressing dual TCRs. Nature Immunology 2010 11 7 628 634 2-s2.0-77953758560 10.1038/ni.1888
9. + T cells in a model for multiple sclerosis. Journal of Experimental Medicine 2001 194 5 669 676 2-s2.0-0035801332 10.1084/jem.194.5.669
10. + T-cell responses to human myelin protein-derived peptides. Proceedings of the National Academy of Sciences of the United States of America 1994 91 23 10859 10863 2-s2.0-0028143869 10.1073/pnas.91.23.10859
11. Gilden D. H., Infectious causes of multiple sclerosis. Lancet Neurology 2005 4 3 195 202 2-s2.0-13944253325 10.1016/S1474-4422(05)01017-3
12. Cook S. D., Dowling P. C., Multiple sclerosis and viruses: an overview. Neurology 1980 30 7, part 2 80 91 2-s2.0-0018974690
13. Kurtzke J. F., Epidemiologic evidence for multiple sclerosis as an infection. Clinical Microbiology Reviews 1993 6 4 382 427 2-s2.0-0027421126
14. Cermelli C., Jacobson S., Viruses and multiple sclerosis. Viral Immunology 2000 13 3 255 267 2-s2.0-0033807935
15. Kuerten S., Gruppe T. L., Laurentius L.-M., Kirch C., Tary-Lehmann M., Lehmann P. V., Addicks K., Differential patterns of spinal cord pathology induced by MP4, MOG peptide 35-55, and PLP peptide 178-191 in C57BL/6 mice. APMIS 2011 119 6 336 346 2-s2.0-79955971449 10.1111/j.1600-0463.2011.02744.x
16. Dal Canto M. C., Kim B. S., Miller S. D., Melvold R. W., Theiler's murine encephalomyelitis virus (TMEV)-induced demyelination: a model for human multiple sclerosis. Methods 1996 10 3 453 461 2-s2.0-0030561071 10.1006/meth.1996.0123
17. Oleszak E. L., Chang J. R., Friedman H., Katsetos C. D., Platsoucas C. D., Theiler's virus infection: a model for multiple sclerosis. Clinical Microbiology Reviews 2004 17 1 174 207 2-s2.0-1642474429 10.1128/CMR.17.1.174- 207.2004
18. Houtman J. J., Fleming J. O., Pathogenesis of mouse hepatitis virus-induced demyelination. Journal of NeuroVirology 1996 2 6 361 376 2-s2.0-0030461287
19. Lavi E., Gilden D. H., Wroblewska Z., Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology 1984 34 5 597 603 2-s2.0-0021343397
20. Stohlman S. A., Weiner L. P., Chronic central nervous system demyelination in mice after JHM virus infection. Neurology 1981 31 1 38 44 2-s2.0-0019350439
21. Weiner L. P., Pathogenesis of demyelination induced by a mouse hepatitis. Archives of Neurology 1973 28 5 298 303 2-s2.0-0015623225
22. Lavi E., Gilden D. H., Highkin M. K., Weiss S. R., Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization. Journal of Virology 1984 51 2 563 566 2-s2.0-0021268022
23. Perlman S., Jacobson G., Olson A. L., Afifi A., Identification of the spinal cord as a major site of persistence during chronic infection with a murine coronavirus. Virology 1990 175 2 418 426 2-s2.0-0025364080 10.1016/0042-6822(90)90426-R
24. Gombold J. L., Weiss S. R., Mouse Hepatitis Virus A59 increases steady-state levels of MHC mRNAs in primary glial cell cultures and in the murine Central Nervous System. Microbial Pathogenesis 1992 13 6 493 505 2-s2.0-0027034762 10.1016/0882-4010(92)90015-G
25. Lavi E., Suzumura A., Lampson L. A., Siegel R. M., Murasko D. M., Silberberg D. H., Weiss S. R., Expression of MHC class I genes in mouse hepatitis virus (MHV-A59) infection and in multiple sclerosis. Advances in Experimental Medicine and Biology 1987 218 219 222 2-s2.0-0023511689
26. Lavi E., Suzumura A., Murray E. M., Silberberg D. H., Weiss S. R., Induction of MHC class I antigens on glial cells is dependent on persistent mouse hepatitis virus infection. Journal of Neuroimmunology 1989 22 2 107 111 2-s2.0-0024498419 10.1016/0165-5728(89)90040-4
27. Suzumura A., Lavi E., Weiss S. R., Silberberg D. H., Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes. Science 1986 232 4753 991 993 2-s2.0-0022448852
28. Suzumura A., Lavi E., Bhat S., Murasko D., Weiss S. R., Silberberg D. H., Induction of glial cell MHC antigen expression in neurotropic coronavirus infections. Characterization of the H-2-inducing soluble factor elaborated by infected brain cells. Journal of Immunology 1988 140 6 2068 2072 2-s2.0-0023916240
29. Matthews A. E., Lavi E., Weiss S. R., Paterson Y., Neither B cells nor T cells are required for CNS demyelination in mice persistently infected with MHV-A59. Journal of NeuroVirology 2002 8 3 257 264 2-s2.0-0036306816 10.1080/13550280290049697
30. + T cells are not major effectors of mouse hepatitis virus A59-induced demyelinating disease. Journal of NeuroVirology 1997 3 3 225 228 2-s2.0-0030844558
31. Das Sarma J., Kenyon L. C., Hingley S. T., Shindler K. S., Mechanisms of primary axonal damage in a viral model of multiple sclerosis. Journal of Neuroscience 2009 29 33 10272 10280 2-s2.0-69049106485 10.1523/JNEUROSCI.1975- 09.2009
32. Das Sarma J., Ciric B., Marek R., Sadhukhan S., Caruso M. L., Shafagh J., Fitzgerald D. C., Shindler K. S., Rostami A. M., Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis. Journal of Neuroinflammation 2009 6, article 14 2-s2.0-67449155295 10.1186/1742-2094-6-14
33. Fitzgerald D. C., Ciric B., Touil T., Harle H., Grammatikopolou J., Das Sarma J., Gran B., Zhang G.-X., Rostami A., Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. Journal of Immunology 2007 179 5 3268 3275 2-s2.0-35648988381
34. Das Sarma J., Iacono K., Gard L., Marek R., Kenyon L. C., Koval M., Weiss S. R., Demyelinating and nondemyelinating strains of mouse hepatitis virus differ in their neural cell tropism. Journal of Virology 2008 82 11 5519 5526 2-s2.0-43949097556 10.1128/JVI.01488-07
35. Shindler K. S., Kenyon L. C., Dutt M., Hingley S. T., Das Sarma J., Experimental optic neuritis induced by a demyelinating strain of mouse hepatitis virus. Journal of Virology 2008 82 17 8882 8886 2-s2.0-50149098558 10.1128/JVI.00920-08
36. Das Sarma J., Scheen E., Seo S.-H., Koval M., Weiss S. R., Enhanced green fluorescent protein expression may be used to monitor murine coronavirus spread in vitro and in the mouse central nervous system. Journal of NeuroVirology 2002 8 5 381 391 2-s2.0-1842859786 10.1080/13550280260422686
37. Reed L. J., Muench H., A simple method of estimating fifty per cent endpoints. American Journal of Epidemiology 1938 27 3 493 497 2-s2.0-33745158157
38. Sarma J. D., Fu L., Hingley S. T., Lavi E., Mouse hepatitis virus type-2 infection in mice: an experimental model system of acute meningitis and hepatitis. Experimental and Molecular Pathology 2001 71 1 1 12 2-s2.0-0034860483 10.1006/exmp.2001.2378
39. Das Sarma J., Fu L., Tsai J. C., Weiss S. R., Lavi E., Demyelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus. Journal of Virology 2000 74 19 9206 9213 2-s2.0-0033808456 10.1128/JVI.74.19.9206-9213.2000
40. Phillips J. J., Chua M. M., Rall G. F., Weiss S. R., Murine coronavirus spike glycoprotein mediates degree of viral spread, inflammation, and virus-induced immunopathology in the central nervous system. Virology 2002 301 1 109 120 2-s2.0-0036396869 10.1006/viro.2002.1551
41. Navas S., Seo S.-H., Chua M. M., Sarma J. D., Lavi E., Hingley S. T., Weiss S. R., Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis. Journal of Virology 2001 75 5 2452 2457 2-s2.0-0035127581 10.1128/JVI.75.5.2452-2457.2001